Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 5011 AL 5025

The effects of fenugreek seed extract supplementation in patients with Alzheimer's disease: A randomized, double-blind, placebo-controlled trial

Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M, Shogofteh F, Zarghi A.

Phytother Res. 2023 Jan;37(1):285-294. doi: 10.1002/ptr.7612. Epub 2022 Oct 5.

Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell-type lipidomics

Asante I, Louie S, Yassine HN.

Ann N Y Acad Sci. 2022 Dec;1518(1):84-105. doi: 10.1111/nyas.14907. Epub 2022 Oct 6.

Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease

Li Y, Xia X, Wang Y, Zheng JC.

J Neuroinflammation. 2022 Oct 6;19(1):248. doi: 10.1186/s12974-022-02613-9.

Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress

Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A, Javvaji K, Pradhan SR, Vallamkondu J, Dey A, Kalra RS, Jha NK, Jha SK, Reddy PH, Kandimalla R.

Free Radic Biol Med. 2022 Nov 20;193(Pt 1):134-157. doi: 10.1016/j.freeradbiomed.2022.09.032. Epub 2022 Oct 4.

Aluminum neurotoxicity and autophagy: a mechanistic view

Makhdoomi S, Ariafar S, Mirzaei F, Mohammadi M.

Neurol Res. 2023 Mar;45(3):216-225. doi: 10.1080/01616412.2022.2132727. Epub 2022 Oct 8.

Zinc-dependent deacetylases (HDACs) as potential targets for treating Alzheimer's disease

Li Y, Lin S, Gu Z, Chen L, He B.

Bioorg Med Chem Lett. 2022 Nov 15;76:129015. doi: 10.1016/j.bmcl.2022.129015. Epub 2022 Oct 5.

Evaluating Cannabis sativa L.'s neuroprotection potential: From bench to bedside

Laws JS 3rd, Smid SD.

Phytomedicine. 2022 Dec;107:154485. doi: 10.1016/j.phymed.2022.154485. Epub 2022 Sep 29.

Hypothesis review: Alzheimer's overture guidelines

Ferrer I.

Brain Pathol. 2023 Jan;33(1):e13122. doi: 10.1111/bpa.13122. Epub 2022 Oct 12.

Survival and causes of death among people with clinically diagnosed dementia with Lewy bodies: A multicenter cohort study

Zuo M, Yue W, Zhang D, Liu S, Gan J, Wang XD, Wu H, Ji Y.

Int J Geriatr Psychiatry. 2022 Nov;37(11). doi: 10.1002/gps.5826.

Alzheimer's disease large-scale gene expression portrait identifies exercise as the top theoretical treatment

Hill MA, Gammie SC.

Sci Rep. 2022 Oct 13;12(1):17189. doi: 10.1038/s41598-022-22179-z.

Populations of Tau Conformers Drive Prion-like Strain Effects in Alzheimer's Disease and Related Dementias

Hromadkova L, Siddiqi MK, Liu H, Safar JG.

Cells. 2022 Sep 26;11(19):2997. doi: 10.3390/cells11192997.

Non-Pharmacological Therapeutic Options for the Treatment of Alzheimer's Disease

Huynh QS, Elangovan S, Holsinger RMD.

Int J Mol Sci. 2022 Sep 20;23(19):11037. doi: 10.3390/ijms231911037.

Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?

Sala-Jarque J, Zimkowska K, Ávila J, Ferrer I, Del Río JA.

Int J Mol Sci. 2022 Sep 29;23(19):11527. doi: 10.3390/ijms231911527.

Conformational Essentials Responsible for Neurotoxicity of Aβ42 Aggregates Revealed by Antibodies against Oligomeric Aβ42

Song C, Zhang T, Zhang Y.

Molecules. 2022 Oct 10;27(19):6751. doi: 10.3390/molecules27196751.

The central role of tau in Alzheimer's disease: From neurofibrillary tangle maturation to the induction of cell death

Thal DR, Tomé SO.

Brain Res Bull. 2022 Nov;190:204-217. doi: 10.1016/j.brainresbull.2022.10.006. Epub 2022 Oct 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias